Startups
LimmaTech Biologics

LimmaTech Biologics

https://lmtbio.com

Self-adjuvanting and multi-antigen vaccine technology platform.

Summary

Seedtable Score
  • 37
Locations
Company Size
  • 11 to 50 employees
Last Stage Round
  • Series A
Industry

Total funding Amount

$39M

Fundraising History

  • Feb 01 '24 Series A
    $3M
  • Oct 09 '23 Series A
    $37M

Investors

  • Novo A/S
    Series A
  • Adjuvant Capital
    Series A
  • Tenmile
    Series A
  • AXA Investment Managers
    Series A
  • Repair Impact Fund
    Series A